NANOVIRICIDES, INC. Research and Development Expense
NANOVIRICIDES, INC. (NNVC) reported Research and Development Expense of $1.29 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-05-15
- NANOVIRICIDES, INC. research and development expense for the quarter ending 2026-03-31 was $1.29M, a 0.29% increase year-over-year.
- NANOVIRICIDES, INC. research and development expense for the quarter ending 2025-12-31 was $1.12M, a 3.26% decline year-over-year.
- NANOVIRICIDES, INC. research and development expense for the quarter ending 2025-09-30 was $993.07K, a 48.63% decline year-over-year.
- NANOVIRICIDES, INC. research and development expense for the quarter ending 2025-06-30 was $1.18M, a 0.40% decline year-over-year.
- NANOVIRICIDES, INC. research and development expense for fiscal 2025 was $5.55M, a 2.06% increase from fiscal 2024.
- NANOVIRICIDES, INC. research and development expense for fiscal 2024 was $5.44M, a 14.94% decline from fiscal 2023.
- NANOVIRICIDES, INC. research and development expense for fiscal 2023 was $6.39M, a 10.50% increase from fiscal 2022.
- NANOVIRICIDES, INC. research and development expense for fiscal 2022 was $5.78M, a 5.39% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 77 month | Research and Development Expense 80 month | Research and Development Expense 83 month | Research and Development Expense 86 month | Research and Development Expense 89 month | Research and Development Expense 92 month | Research and Development Expense 95 month | Research and Development Expense 99 month | Research and Development Expense 101 month | Research and Development Expense 104 month | Research and Development Expense 107 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $1.29M 10-Q · filed 2026-05-15 | $2.40M derived: sum of 2 quarters · filed 2026-05-15 | $3.40M 10-Q · filed 2026-05-15 | $4.58M derived: sum of 4 quarters · filed 2026-05-15 | |||||||||||||||
| 2025-12-31 | $1.12M 10-Q · filed 2026-02-17 | $2.11M 10-Q · filed 2026-02-17 | $3.29M derived: sum of 3 quarters · filed 2026-02-17 | $4.57M derived: sum of 4 quarters · filed 2026-05-15 | |||||||||||||||
| 2025-09-30 | $993.07K 10-Q · filed 2025-11-14 | $2.17M derived: sum of 2 quarters · filed 2025-11-14 | $3.45M derived: sum of 3 quarters · filed 2026-05-15 | $4.61M derived: sum of 4 quarters · filed 2026-05-15 | |||||||||||||||
| 2025-06-30 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $2.46M derived: sum of 2 quarters · filed 2026-05-15 | $3.62M derived: sum of 3 quarters · filed 2026-05-15 | $5.55M 10-K · filed 2025-09-29 | |||||||||||||||
| 2025-03-31 | $1.28M 10-Q · filed 2026-05-15 | $2.44M derived: sum of 2 quarters · filed 2026-05-15 | $4.37M 10-Q · filed 2026-05-15 | $5.55M derived: sum of 4 quarters · filed 2026-05-15 | |||||||||||||||
| 2024-12-31 | $1.16M 10-Q · filed 2026-02-17 | $3.09M 10-Q · filed 2026-02-17 | $4.27M derived: sum of 3 quarters · filed 2026-02-17 | $5.49M derived: sum of 4 quarters · filed 2026-02-17 | |||||||||||||||
| 2024-09-30 | $1.93M 10-Q · filed 2025-11-14 | $3.12M derived: sum of 2 quarters · filed 2025-11-14 | $4.33M derived: sum of 3 quarters · filed 2025-11-14 | $5.90M derived: sum of 4 quarters · filed 2025-11-14 | |||||||||||||||
| 2024-06-30 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $2.40M derived: sum of 2 quarters · filed 2025-09-29 | $3.97M derived: sum of 3 quarters · filed 2025-09-29 | $5.44M 10-K · filed 2025-09-29 | |||||||||||||||
| 2024-03-31 | $1.21M 10-Q · filed 2025-05-15 | $2.79M derived: sum of 2 quarters · filed 2025-05-15 | $4.26M 10-Q · filed 2025-05-15 | $7.17M derived: sum of 4 quarters · filed 2025-05-15 | |||||||||||||||
| 2023-12-31 | $1.57M 10-Q · filed 2025-02-14 | $3.04M 10-Q · filed 2025-02-14 | $5.95M derived: sum of 3 quarters · filed 2025-02-14 | $7.15M derived: sum of 4 quarters · filed 2025-02-14 | |||||||||||||||
| 2023-09-30 | $1.47M 10-Q · filed 2024-11-14 | $4.38M derived: sum of 2 quarters · filed 2024-11-14 | $5.58M derived: sum of 3 quarters · filed 2024-11-14 | $6.75M derived: sum of 4 quarters · filed 2024-11-14 | |||||||||||||||
| 2023-06-30 | $2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-27 | $4.11M derived: sum of 2 quarters · filed 2024-09-27 | $5.28M derived: sum of 3 quarters · filed 2024-09-27 | $6.39M 10-K · filed 2024-09-27 | |||||||||||||||
| 2023-03-31 | $1.20M 10-Q · filed 2024-05-15 | $2.37M derived: sum of 2 quarters · filed 2024-05-15 | $3.48M 10-Q · filed 2024-05-15 | $4.65M derived: sum of 4 quarters · filed 2024-05-15 | |||||||||||||||
| 2022-12-31 | $1.17M 10-Q · filed 2024-02-14 | $2.28M 10-Q · filed 2024-02-14 | $3.45M derived: sum of 3 quarters · filed 2024-02-14 | $4.71M derived: sum of 4 quarters · filed 2024-02-14 | |||||||||||||||
| 2022-09-30 | $1.11M 10-Q · filed 2023-11-14 | $2.28M derived: sum of 2 quarters · filed 2023-11-14 | $3.54M derived: sum of 3 quarters · filed 2023-11-14 | $4.80M derived: sum of 4 quarters · filed 2023-11-14 | |||||||||||||||
| 2022-06-30 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-13 | $2.43M derived: sum of 2 quarters · filed 2023-10-13 | $3.69M derived: sum of 3 quarters · filed 2023-10-13 | $5.78M 10-K · filed 2023-10-13 | |||||||||||||||
| 2022-03-31 | $1.26M 10-Q · filed 2023-05-15 | $2.52M derived: sum of 2 quarters · filed 2023-05-15 | $4.61M 10-Q · filed 2023-05-15 | $6.20M derived: sum of 4 quarters · filed 2023-05-15 | |||||||||||||||
| 2021-12-31 | $1.26M 10-Q · filed 2023-02-14 | $3.36M 10-Q · filed 2023-02-14 | $4.94M derived: sum of 3 quarters · filed 2023-02-14 | $6.41M derived: sum of 4 quarters · filed 2023-02-14 | |||||||||||||||
| 2021-09-30 | $2.10M 10-Q · filed 2022-11-14 | $3.68M derived: sum of 2 quarters · filed 2022-11-14 | $5.15M derived: sum of 3 quarters · filed 2022-11-14 | $6.64M derived: sum of 4 quarters · filed 2022-11-14 | |||||||||||||||
| 2021-06-30 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-13 | $3.05M derived: sum of 2 quarters · filed 2022-10-13 | $4.54M derived: sum of 3 quarters · filed 2022-10-13 | $6.11M 10-K · filed 2022-10-13 | |||||||||||||||
| 2021-03-31 | $1.46M 10-Q · filed 2022-05-16 | $2.96M derived: sum of 2 quarters · filed 2022-05-16 | $4.53M 10-Q · filed 2022-05-16 | $5.60M derived: sum of 4 quarters · filed 2022-05-16 | |||||||||||||||
| 2020-12-31 | $1.49M 10-Q · filed 2022-02-14 | $3.07M 10-Q · filed 2022-02-14 | $4.13M derived: sum of 3 quarters · filed 2022-02-14 | $5.27M derived: sum of 4 quarters · filed 2022-02-14 | |||||||||||||||
| 2020-09-30 | $1.57M 10-Q · filed 2021-11-15 | $2.64M derived: sum of 2 quarters · filed 2021-11-15 | $3.77M derived: sum of 3 quarters · filed 2021-11-15 | $4.79M derived: sum of 4 quarters · filed 2021-11-15 | |||||||||||||||
| 2020-06-30 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-12 | $2.20M derived: sum of 2 quarters · filed 2021-10-12 | $3.21M derived: sum of 3 quarters · filed 2021-10-12 | $4.70M 10-K · filed 2021-10-12 | |||||||||||||||
| 2020-03-31 | $1.13M 10-Q · filed 2021-05-14 | $2.15M derived: sum of 2 quarters · filed 2021-05-14 | $3.63M 10-Q · filed 2021-05-14 | $5.22M derived: sum of 4 quarters · filed 2021-10-12 | |||||||||||||||
| 2019-12-31 | $1.01M 10-Q · filed 2021-02-16 | $2.49M 10-Q · filed 2021-02-16 | $4.08M derived: sum of 3 quarters · filed 2021-10-12 | $5.39M derived: sum of 4 quarters · filed 2021-10-12 | |||||||||||||||
| 2019-09-30 | $1.48M 10-Q · filed 2020-11-16 | $3.07M derived: sum of 2 quarters · filed 2021-10-12 | $4.38M derived: sum of 3 quarters · filed 2021-10-12 | $6.04M derived: sum of 4 quarters · filed 2021-10-12 | |||||||||||||||
| 2019-06-30 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-12 | $2.90M derived: sum of 2 quarters · filed 2021-10-12 | $4.55M derived: sum of 3 quarters · filed 2021-10-12 | $5.92M 10-K · filed 2021-10-12 | |||||||||||||||
| 2019-03-31 | $1.31M 10-Q · filed 2020-06-22 | $2.97M derived: sum of 2 quarters · filed 2020-06-22 | $4.34M 10-Q · filed 2020-06-22 | $5.91M derived: sum of 4 quarters · filed 2020-10-13 | |||||||||||||||
| 2018-12-31 | $1.66M 10-Q · filed 2020-02-14 | $3.02M 10-Q · filed 2020-02-14 | $4.60M derived: sum of 3 quarters · filed 2020-10-13 | $5.89M derived: sum of 4 quarters · filed 2020-10-13 | |||||||||||||||
| 2018-09-30 | $1.41M 10-Q · filed 2019-11-15 | $2.94M derived: sum of 2 quarters · filed 2020-10-13 | $4.23M derived: sum of 3 quarters · filed 2020-10-13 | $5.87M derived: sum of 4 quarters · filed 2020-10-13 | |||||||||||||||
| 2018-06-30 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-13 | $2.82M derived: sum of 2 quarters · filed 2020-10-13 | $4.46M derived: sum of 3 quarters · filed 2020-10-13 | $5.91M 10-K · filed 2020-10-13 | $4.83M 10-K · filed 2018-10-12 | ||||||||||||||
| 2018-03-31 | $1.29M 10-Q · filed 2019-05-15 | $1.03M 10-Q · filed 2018-05-21 | $2.93M derived: sum of 2 quarters · filed 2019-05-15 | $4.38M 10-Q · filed 2019-05-15 | $3.57M 10-Q · filed 2018-05-21 | $6.68M derived: sum of 4 quarters · filed 2019-08-23 | |||||||||||||
| 2017-12-31 | $1.64M 10-Q · filed 2019-02-14 | $1.39M 10-Q · filed 2018-02-20 | $3.09M 10-Q · filed 2019-02-14 | $2.54M 10-Q · filed 2018-02-20 | $5.39M derived: sum of 3 quarters · filed 2019-08-23 | $6.94M derived: sum of 4 quarters · filed 2019-08-23 | |||||||||||||
| 2017-09-30 | $1.45M 10-Q · filed 2018-11-14 | $1.16M 10-Q · filed 2017-11-14 | $3.75M derived: sum of 2 quarters · filed 2019-08-23 | $5.30M derived: sum of 3 quarters · filed 2019-08-23 | $6.57M derived: sum of 4 quarters · filed 2019-08-23 | ||||||||||||||
| 2017-06-30 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-23 | $3.85M derived: sum of 2 quarters · filed 2019-08-23 | $5.11M derived: sum of 3 quarters · filed 2019-08-23 | $6.57M 10-K · filed 2019-08-23 | $5.53M 10-K · filed 2017-09-28 | ||||||||||||||
| 2017-03-31 | $1.56M 10-Q · filed 2018-05-21 | $2.82M derived: sum of 2 quarters · filed 2018-05-21 | $4.27M 10-Q · filed 2018-05-21 | $5.87M derived: sum of 4 quarters · filed 2018-10-12 | |||||||||||||||
| 2016-12-31 | $1.26M 10-Q · filed 2018-02-20 | $2.71M 10-Q · filed 2018-02-20 | $4.32M derived: sum of 3 quarters · filed 2018-10-12 | $5.38M derived: sum of 4 quarters · filed 2018-10-12 | |||||||||||||||
| 2016-09-30 | $1.45M 10-Q · filed 2017-11-14 | $3.05M derived: sum of 2 quarters · filed 2018-10-12 | $4.12M derived: sum of 3 quarters · filed 2018-10-12 | $5.27M derived: sum of 4 quarters · filed 2018-10-12 | |||||||||||||||
| 2016-06-30 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-12 | $2.67M derived: sum of 2 quarters · filed 2018-10-12 | $3.82M derived: sum of 3 quarters · filed 2018-10-12 | $5.03M 10-K · filed 2018-10-12 | |||||||||||||||
| 2016-03-31 | $1.07M 10-Q · filed 2017-05-15 | $2.22M derived: sum of 2 quarters · filed 2017-05-15 | $3.43M 10-Q · filed 2017-05-15 | $4.89M derived: sum of 4 quarters · filed 2017-09-28 | |||||||||||||||
| 2015-12-31 | $1.15M 10-Q · filed 2017-02-14 | $2.36M 10-Q · filed 2017-02-14 | $3.82M derived: sum of 3 quarters · filed 2017-09-28 | $4.37M derived: sum of 4 quarters · filed 2017-09-28 | |||||||||||||||
| 2015-09-30 | $1.28M 10-Q · filed 2016-11-14 | $2.67M derived: sum of 2 quarters · filed 2017-09-28 | $3.21M derived: sum of 3 quarters · filed 2017-09-28 | $4.13M derived: sum of 4 quarters · filed 2017-09-28 | |||||||||||||||
| 2015-06-30 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | $1.93M derived: sum of 2 quarters · filed 2017-09-28 | $2.85M derived: sum of 3 quarters · filed 2017-09-28 | $3.66M 10-K · filed 2017-09-28 | |||||||||||||||
| 2015-03-31 | $546.46K 10-Q · filed 2016-05-10 | $1.46M derived: sum of 2 quarters · filed 2016-05-10 | $2.27M 10-Q · filed 2016-05-10 | $4.48M derived: sum of 4 quarters · filed 2016-09-16 | |||||||||||||||
| 2014-12-31 | $916.74K 10-Q · filed 2016-02-09 | $1.73M 10-Q · filed 2016-02-09 | $3.93M derived: sum of 3 quarters · filed 2016-09-16 | $4.55M derived: sum of 4 quarters · filed 2016-09-16 | |||||||||||||||
| 2014-09-30 | $811.11K 10-Q · filed 2015-11-09 | $3.01M derived: sum of 2 quarters · filed 2016-09-16 | $3.64M derived: sum of 3 quarters · filed 2016-09-16 | $4.77M derived: sum of 4 quarters · filed 2016-09-16 | |||||||||||||||
| 2014-06-30 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-16 | $2.83M derived: sum of 2 quarters · filed 2016-09-16 | $3.96M derived: sum of 3 quarters · filed 2016-09-16 | $5.13M 10-K · filed 2016-09-16 | |||||||||||||||
| 2014-03-31 | $625.74K 10-Q · filed 2015-05-15 | $1.76M derived: sum of 2 quarters · filed 2015-05-15 | $2.93M 10-Q · filed 2015-05-15 | $3.94M derived: sum of 4 quarters · filed 2015-09-14 | $25.73M 10-Q · filed 2014-05-15 | ||||||||||||||
| 2013-12-31 | $1.13M 10-Q · filed 2015-02-25 | $2.30M 10-Q · filed 2015-02-25 | $3.32M derived: sum of 3 quarters · filed 2015-09-14 | $4.68M derived: sum of 4 quarters · filed 2015-09-14 | $25.11M 10-Q · filed 2014-02-14 | ||||||||||||||
| 2013-09-30 | $1.17M 10-Q/A · filed 2015-02-23 | $2.19M derived: sum of 2 quarters · filed 2015-09-14 | $3.55M derived: sum of 3 quarters · filed 2015-09-14 | $4.26M derived: sum of 4 quarters · filed 2015-09-14 | $23.98M 10-Q/A · filed 2013-11-18 | ||||||||||||||
| 2013-06-30 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-14 | $2.37M derived: sum of 2 quarters · filed 2015-09-14 | $3.08M derived: sum of 3 quarters · filed 2015-09-14 | $4.29M 10-K · filed 2015-09-14 | $22.80M 10-K/A · filed 2013-10-08 | ||||||||||||||
| 2013-03-31 | $1.36M 10-Q · filed 2014-05-15 | $2.07M derived: sum of 2 quarters · filed 2014-05-15 | $3.28M 10-Q · filed 2014-05-15 | $4.29M derived: sum of 4 quarters · filed 2015-02-23 | $21.79M 10-Q/A · filed 2013-05-20 | ||||||||||||||
| 2012-12-31 | $710.20K 10-Q · filed 2014-02-14 | $1.92M 10-Q · filed 2014-02-14 | $2.93M derived: sum of 3 quarters · filed 2015-02-23 | $4.52M derived: sum of 4 quarters · filed 2015-02-23 | $20.43M 10-Q/A · filed 2013-02-22 | ||||||||||||||
| 2012-09-30 | $1.21M 10-Q/A · filed 2013-11-18 | $2.22M derived: sum of 2 quarters · filed 2015-02-23 | $3.81M derived: sum of 3 quarters · filed 2015-02-23 | $4.82M derived: sum of 4 quarters · filed 2015-02-23 | $19.72M 10-Q · filed 2012-11-19 | ||||||||||||||
| 2012-06-30 | $1.01M derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-02-23 | $2.60M derived: sum of 2 quarters · filed 2015-02-23 | $3.61M derived: sum of 3 quarters · filed 2015-02-23 | $4.27M 10-K · filed 2015-02-23 | $18.51M 10-K/A · filed 2012-10-26 | ||||||||||||||
| 2012-03-31 | $1.58M 10-Q/A · filed 2013-05-20 | $2.59M derived: sum of 2 quarters · filed 2013-05-20 | $3.25M 10-Q/A · filed 2013-05-20 | $3.92M derived: sum of 4 quarters · filed 2013-05-20 | $17.50M 10-Q · filed 2012-05-21 | ||||||||||||||
| 2011-12-31 | $1.01M 10-Q/A · filed 2013-02-22 | $1.67M 10-Q/A · filed 2013-02-22 | $2.33M derived: sum of 3 quarters · filed 2013-02-22 | $3.99M derived: sum of 4 quarters · filed 2013-02-22 | $15.92M 10-Q · filed 2012-02-14 | ||||||||||||||
| 2011-09-30 | $691.70K 10-Q · filed 2012-11-19 | $1.32M derived: sum of 2 quarters · filed 2012-11-19 | $2.98M derived: sum of 3 quarters · filed 2012-11-19 | $4.09M derived: sum of 4 quarters · filed 2012-11-19 | $14.94M 10-Q/A · filed 2011-12-12 | ||||||||||||||
| 2011-06-30 | $631.06K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-10-26 | $2.28M derived: sum of 2 quarters · filed 2012-10-26 | $3.40M derived: sum of 3 quarters · filed 2012-10-26 | $4.16M 10-K/A · filed 2012-10-26 | |||||||||||||||
| 2011-03-31 | $1.65M 10-Q · filed 2012-05-21 | $2.77M derived: sum of 2 quarters · filed 2012-05-21 | $3.52M 10-Q · filed 2012-05-21 | ||||||||||||||||
| 2010-12-31 | $1.11M 10-Q · filed 2012-02-14 | $1.87M 10-Q · filed 2012-02-14 | |||||||||||||||||
| 2010-09-30 | $750.13K 10-Q/A · filed 2011-12-12 | ||||||||||||||||||
| 2010-06-30 | $3.37M 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |